Public Petition Launched to Modernize Medical Cannabis Home-Grow Rules
Connecticut medical cannabis patients and supporters now have an opportunity to put their voices behind a formal effort to change the state’s medical home cultivation rules.
Front Page › Archive › Topic
9 stories on this topic.
Connecticut medical cannabis patients and supporters now have an opportunity to put their voices behind a formal effort to change the state’s medical home cultivation rules.
That is the date the United States government was granted U.S. Patent No. 6,630,507 for cannabinoids, formally recognizing them as compounds with medical value, including antioxidant and neuroprotective properties with potential applications in conditions such as Alzheimer’s disease, Parkinson’s disease, and stroke.
The 2025 Medical Cannabis Caregiver Bill HB 5429 came closer than most people realize to breaking through and passing to the house.
O’Dea is pointing directly at cultivation concerns in the regulated market and acknowledging a reality policymakers rarely say out loud: the legacy market hasn’t gone anywhere, for a reason.
Connecticut lawmakers are advancing a cannabis amendment that quietly does something extraordinary.
Connecticut’s legal cannabis industry has a messaging problem.
Over the past year, Connecticut cannabis companies have increasingly claimed that converting recreational dispensaries into “hybrid” locations serving both adult-use customers and medical patients is about compassion and expanding care.
Every time you buy a cannabis product from a dispensary in Connecticut — especially a THC beverage — your dollars are not just paying for overpriced product and corporate profits. They are being funneled straight into a state enforcement fund that bankrolls the Department of Consumer Protection (DCP) to investigate, penalize, and shut down cannabis and hemp operators across the
Connecticut cannabis patients need to be aware: recent laboratory results show that some products currently passing state testing would fail in most other states due to excessive yeast & mold contamination. For patients with compromised immune systems, asthma, or mold sensitivities, these results should be treated as a red flag.